Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence

Detalles Bibliográficos
Autores principales: Sookaromdee, Pathum, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652038/
https://www.ncbi.nlm.nih.gov/pubmed/36369624
http://dx.doi.org/10.1007/s42000-022-00420-8
_version_ 1784828377394315264
author Sookaromdee, Pathum
Wiwanitkit, Viroj
author_facet Sookaromdee, Pathum
Wiwanitkit, Viroj
author_sort Sookaromdee, Pathum
collection PubMed
description
format Online
Article
Text
id pubmed-9652038
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-96520382022-11-14 Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence Sookaromdee, Pathum Wiwanitkit, Viroj Hormones (Athens) Letter to the Editor Springer International Publishing 2022-11-11 2023 /pmc/articles/PMC9652038/ /pubmed/36369624 http://dx.doi.org/10.1007/s42000-022-00420-8 Text en © The Author(s), under exclusive licence to Hellenic Endocrine Society 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Sookaromdee, Pathum
Wiwanitkit, Viroj
Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence
title Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence
title_full Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence
title_fullStr Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence
title_full_unstemmed Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence
title_short Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence
title_sort patients with type 2 diabetes mellitus and response to covid-19 bnt162b2 mrna vaccine: correspondence
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652038/
https://www.ncbi.nlm.nih.gov/pubmed/36369624
http://dx.doi.org/10.1007/s42000-022-00420-8
work_keys_str_mv AT sookaromdeepathum patientswithtype2diabetesmellitusandresponsetocovid19bnt162b2mrnavaccinecorrespondence
AT wiwanitkitviroj patientswithtype2diabetesmellitusandresponsetocovid19bnt162b2mrnavaccinecorrespondence

Ejemplares similares